Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with verticals in industries, including artificial intelligence, machine learning, and healthcare. Its products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and dark Web, making predictive analytics. This platform provides insights into market trends and direct customer feedback. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amount of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform.


TSXV:DM - Post by User

Comment by jombyon Apr 13, 2021 3:07am
211 Views
Post# 32983266

RE:RE:SCRN

RE:RE:SCRN
oronto, Ontario--(Newsfile Corp. - April 13, 2021) - ScreenPro Security Inc. (CSE: SCRN) ("ScreenPro" or the "Company") is pleased to announce that it has commenced a new business line providing rapid antigen testing for individuals and corporations with its newly approved Health Canada Rapid Antigen tests. The ScreenPro test are administered by our team of trained nurses and provide results in 10 minutes. By initiating this new platform, the Company has lowered the financial barrier for testing to as little as $60 per test making this a much more affordable option for individuals looking for piece of mind and corporations wanting to ensure a safe and secure workplace environment. This is a significant step for ScreenPro in achieving the Company's core strategy- getting Canadians back to work and school safely.

ScreenPro's rapid antigen test kit, with over 94% sensitivity, is a point-of-care offering where a trained nurse will collect a sample from the client using a nasal swab. When compared with the traditional PCR testing, rapid testing enables the employer to test larger groups of employees in a shorter period of time at a significant cost saving. By trusting ScreenPro and its trained nurses for testing purposes, if a positive case is identified, the nurses are trained to administer PCR tests and will have them on hand to provide that extra layer of testing and piece of mind. ScreenPro can provide its clients a turnkey solution to ensure everyone in their controlled vicinity (office building, concerts, sporting events) has a negative rapid test result prior to entry. This is key to ensure its clients can provide a safe environment for their employees and customers.

"Businesses need an effective and cost-efficient way to reset and restart their businesses. Rapid testing is one of the most widely in-demand processes and we have the platform and solution to achieve our common goal, back to work," said the Company's CEO, John McMullen. "Our test picks up the new variants and with the rapid spread of this third wave, testing is more important than ever."

The company has already rolled out the tests to its clients and received positive responses for the tests accuracy, ease of use and the time it took to produce the results.

<< Previous
Bullboard Posts
Next >>